Blood and lymphatic system disorders
Semantic Scholar uses AI to extract papers important to this topic.
Background The effects of genetic variants related to the pharmacodynamic mechanisms of immunosuppressive drugs on their… Expand Methods: RTXM83 is a proposed biosimilar developed by mAbxience S.A. to the reference medicine product rituximab (MabThera… Expand Introduction: Non-Hodgkin's lymphoma (NHL) is the sixth most common hematological malignancy in adults, with B-cell lymphomas… Expand AIM
Term and preterm neonates are at high risk for serious adverse drug reactions (ADRs).
A descriptive study of… Expand Introduction The French pharmacovigilance system is coordinated by the French Medicines Agency (‘Agence nationale de securite du… Expand Abstract Objective: Chronic myeloid leukemia (CML) treatment relies on tyrosine kinase inhibitors (TKIs), but their use can be… Expand BackgroundThe nature of adverse drug reactions observed post-authorization for biopharmaceuticals differs from that observed for… Expand PURPOSE
C-1311 is a member of the novel imidazoacridinone family of anticancer agents. This phase 1 trial was designed to… Expand AbstractBackground: Reporting adverse drug reactions (ADRs) has traditionally been the sole province of healthcare professionals… Expand AbstractBackground: The French pharmacovigilance system is based on a network of 31 regional centres located in teaching… Expand